Bolt Biotherapeutics Inc Stock price
Is Bolt Biotherapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Bolt Biotherapeutics Inc Stock Analysis
Analyst Opinions
10 Analysts have issued a Bolt Biotherapeutics Inc forecast:
Analyst Opinions
10 Analysts have issued a Bolt Biotherapeutics Inc forecast:
Don't miss a Thing! We will send you all news about Bolt Biotherapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Bolt Biotherapeutics Inc Stock News
Company Profile
Bolt Biotherapeutics, Inc. is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.
| Head office | United States |
| CEO | Mr. Quinn |
| Employees | 23 |
| Founded | 2015 |
| Website | boltbio.com |


